Related Experiment Videos
Clinical management of human immunodeficiency virus-associated non-Hodgkin's lymphoma
1Department of Medicine, San Francisco General Hospital, University of California, USA.
Journal of the National Cancer Institute. Monographs
|August 26, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Spectral band passes for a high precision satellite sounder.
Applied optics·2010
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Non-completion of colorectal cancer screening among Alaska Native people in an intervention trial.
Journal of the National Cancer Institute. Monographs·2026
Cancer Risk Factors, Screening, and Neighborhood Socioeconomic Deprivation Across the U.S. Urban-to-Frontier Continuum.
Journal of the National Cancer Institute. Monographs·2026
Developments in human papillomavirus vaccines, schedules, and implementation strategies.
Journal of the National Cancer Institute. Monographs·2026
Benefits, harms, and cervical cancer elimination timing of human papillomavirus screening approaches tailored to birth cohort as a proxy for vaccination status in the United States: a comparative modeling study.
Journal of the National Cancer Institute. Monographs·2026
From evidence to practice: leveraging implementation science for transitioning to risk-adapted cervical cancer screening.
Journal of the National Cancer Institute. Monographs·2026
Cervical cancer screening in vaccinated populations: challenges and implications for low- and middle-income countries.
Journal of the National Cancer Institute. Monographs·2026
From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott-Aldrich syndrome.
Regenerative medicine·2026
Primary extranodal marginal zone lymphoma of gastric mucosa-associated lymphoid tissue in children: a case report and review of the literature.
Journal of medical case reports·2026
Beyond MYD88-only testing: MYD88/CD79B profiling improves molecular detection and MCD genotyping in VRL and CNS lymphomas.
Experimental hematology & oncology·2026
Geranylgeranylation is required for B-cell proliferation and plasma cell survival implications for autoimmune therapy.
Cellular & molecular immunology·2026
A microbiota-driven CCL25-CCR9 axis reprograms intestinal ILC2s in the distal small intestine to promote metabolic dysfunction in obesity.
Cellular and molecular gastroenterology and hepatology·2026